Cargando…
SB 206553, a putative 5-HT(2C) inverse agonist, attenuates methamphetamine-seeking in rats
BACKGROUND: Methamphetamine (meth) dependence presents a substantial socioeconomic burden. Despite the need, there is no FDA-approved pharmacotherapy for psychostimulant dependence. We consider 5-HT(2C) receptors as viable therapeutic targets. We recently revealed that the atypical antidepressant, m...
Autores principales: | Graves, Steven M, Napier, T Celeste |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441362/ https://www.ncbi.nlm.nih.gov/pubmed/22697313 http://dx.doi.org/10.1186/1471-2202-13-65 |
Ejemplares similares
-
Similarities between the Binding Sites of SB-206553 at Serotonin Type 2 and Alpha7 Acetylcholine Nicotinic Receptors: Rationale for Its Polypharmacological Profile
por: Möller-Acuña, Patricia, et al.
Publicado: (2015) -
The 5-HT(2C) receptor agonist, lorcaserin, and the 5-HT(6) receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour
por: Higgs, Suzanne, et al.
Publicado: (2015) -
Crystal structure of the human 5-HT(1B) serotonin receptor bound to an inverse agonist
por: Yin, Wanchao, et al.
Publicado: (2018) -
The 5‐HT(2C) receptor as a therapeutic target for alcohol and methamphetamine use disorders: A pilot study in treatment‐seeking individuals
por: Campbell, Erin J., et al.
Publicado: (2021) -
Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats
por: Nawata, Yoko, et al.
Publicado: (2018)